10.22.24 -- The Latest Strategies For Quantifying AAV Capsid Titer

Explore insights from international experts on the rapidly growing CGT field. What are the challenges being faced? What trends are being seen? What are the future directions for cell and gene therapy?

It's important to frequently evaluate your manufacturing process, gauging if improvements can be made. Learn how aseptic connections can impact your efficiency and speed as you continue to scale-up.

It's essential to understand how scaling up is affecting your aseptic filling operations. Here are four topics to consider to help ensure your drug product will be taken care of and ready for production.

Addressing physical instability and high-viscosity issues early when developing ultra-high protein concentration formulations can reduce costs and improve patient outcomes.

See how an innovative optofluidic platform empowers researchers to gain a deeper understanding of single-cell functionality, accelerating the development of effective adoptive cell therapies.

Demands for flexible, scalable, cost effective manufacturing are prompting cell and gene therapy manufacturers and CDMOs to implement single-use technology for manufacturing their therapies.

One solution to drug development challenges is adopting a parallel operations business model. Review recommendations for how parallel operations can be leveraged in a biomanufacturing strategy.

Automated sample purification kits enable consistency while reducing plastic waste and enabling cost-saving for your facility, reducing the overall price per sample.

Explore how MAVERICK’s Raman-based technology delivers instant, reliable measurements of glucose, lactate, and biomass across diverse cell lines, media, and scales.

Uncover how transferring a batch chromatography process into a multi-column format and scaling that process up to continuous perfusion dramatically reduced protein A resin requirements.